EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for URGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -1.994
March 31, 2026 -2.755
December 31, 2025 -3.210
September 30, 2025 -3.462
June 30, 2025 -3.317
March 31, 2025 -3.178
December 31, 2024 -3.221
September 30, 2024 -3.143
June 30, 2024 -3.271
March 31, 2024 -3.393
December 31, 2023 -3.724
September 30, 2023 -4.227
June 30, 2023 -4.683
March 31, 2023 -4.830
December 31, 2022 -4.787
September 30, 2022 -4.832
June 30, 2022 -5.048
March 31, 2022 -5.047
December 31, 2021 -4.958
Date Value
September 30, 2021 -5.067
June 30, 2021 -5.024
March 31, 2021 -5.290
December 31, 2020 -5.911
September 30, 2020 -6.390
June 30, 2020 -6.148
March 31, 2020 -5.786
December 31, 2019 -5.108
September 30, 2019 -4.714
June 30, 2019 -4.926
March 31, 2019 -4.990
December 31, 2018 -4.757
September 30, 2018 -4.034
June 30, 2018 -2.778
March 31, 2018 -2.336
December 31, 2017 -1.46
September 30, 2017 -0.72
June 30, 2017 -0.70

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Xencor, Inc. -2.170
MeiraGTx Holdings Plc 0.7057
Insmed, Inc. -4.105
Ironwood Pharmaceuticals, Inc. 0.7668
Viking Therapeutics, Inc. -4.662